Hexima Share Price and Company Fundamentals
Last traded: Today at 4:34 AM
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is HXP124, which is in a phase IIb clinical trial for the treatment of fungal toenail infections. It operates in the topical antifungal sector of the pharmaceutical product development industry worldwide. The company was founded in 1997 and is headquartered in Melbourne, Australia.
|Primary activities||Research and development of plant-derived proteins and peptides for applications as human therapeutics.|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||La Trobe Institute for Molecular Science Level 4 LIMS 2 La Trobe University Melbourne VIC 3086 Australia|
|Phone / Fax||61 3 9479 1210 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Hexima does not pay dividends.
As of Jul 2021, following are the company executives and directors listed on Hexima.
|Mr. Michael D. A. Aldridge B.Sc., M.A., B.Sc (Hons)., MApFin||MD, CEO & Exec. Director||53||416.47k|
|Ms. Helen Molloy||Financial Controller & Company Sec.||273.17k|
|Dr. Nicole van der Weerden B.Sc., Ph.D., BSc (Hons), MBA (MBS)||COO & Exec. Director||100.2k|
|Prof. Marilyn A. Anderson B.Sc., FAA, BSc (Hons), FT, FAICD, AO||Chief Science Officer & Exec. Director||69||90.99k|
|Dr. Neil Forrester||VP of Bus. Devel.|
|Dr. Yolanda Gaspar||Head of Clinical Operations|
|Dr. Peter J. Welburn||Chief Devel. Officer||68|
|Prof. Adrienne Elizabeth Clarke||Science Advisor||82|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Hexima is 30.1M and its enterprise value is 22.58M. The enterprise value to revenue ratio of HXL is 8.15.
Companies similar to Hexima (HXL)
Hexima (ASX:HXL) Frequently Asked Questions
1. What is Hexima's Stock Symbol?
Hexima trades on ASX under the ticker symbol "HXL".
2. What is Hexima's stock price today?
One share of HXL stock can currently be purchased for approximately $0.23.
3. How can I contact Hexima?
Hexima's mailing address is La Trobe Institute for Molecular Science Level 4 LIMS 2 La Trobe University Melbourne VIC 3086 Australia. The company can be reached via phone at 61 3 9479 1210.
4. What is Hexima's official website?
The official website of Hexima is http://www.hexima.com.au.
5. Which share registry manages Hexima's stock?
Hexima's stock is managed by LINK MARKET SERVICES LIMITED.